Clinical trial

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

NCT06846554

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention APL-9796 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-04-09

PhasePHASE2

Conditions

Pulmonary Arterial Hypertensionverified · MONDO: pulmonary arterial hypertension

Interventions

APL-9796DRUG

Sponsors & collaborators

Apollo Therapeutics Ltdlead sponsor

Mapped research locations

LondonUnited Kingdom1 CambridgeUnited Kingdom1 SheffieldUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06846554 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.